Pneumology
Data update as of 31/12/2025
2025 DATA
Leaders
PIs
Research
|
LocationDepartment of Pneumology 1st Floor Fundación Jiménez Díaz University Hospital. Avda. Reyes Católicos, 2. 28040 Madrid (Spain). Experimental Research Laboratory P1 Floor, Research Institute IIS-FJD Clinical Research Unit KeywordsChronic Obstructive Pulmonary Disease (COPD), emphysema, lung cancer, asthma, sleep apnoea, pulmonary fibrosis, respiratory failure, hypoxia, interventional bronchoscopy. |
Gender perspective
Summary of activities
The group conducts integrated clinical, basic and experimental research as part of the CIBER on Respiratory Diseases (CIBERES), working in multidisciplinary collaboration with other medical specialties and health science disciplines. Research activities are organised around five main areas: COPD, emphysema and lung cancer; sleep apnoea; asthma; respiratory failure and hypoxia (Respiratory Intermediate Care Unit, RICU); and interstitial lung diseases and pulmonary hypertension.
Contributions to society
The IIS-FJD Pneumology group contributed to the Neumomadrid Position Statement on Immunisation of Adult Patients with Respiratory Diseases. The Group also coordinates the population-based lung cancer screening programme, aimed at improving early detection and reducing mortality associated with lung cancer.
Collaborations
- National collaborations:
Within Fundación Jiménez Díaz University Hospital (HUFJD):
Departments of Cardiology, Rheumatology, Allergy, Otorhinolaryngology (ENT) and Immunology.
Other centres and networks:
CIBIR: Basic research group on oncogenes and mediators of lung cancer.
UAM: Basic Research Group on Cellular Damage Induced by Hypoxia and Tobacco Smoke Exposure.
CIBER: Participation in the Airway Inflammatory Diseases Research Programme.
NEREA: Regional research network focused on the characterisation of interstitial lung diseases associated with autoimmune disorders.
REVA: Réseau Européen de Ventilation Artificielle
PII of SEPAR (integrated research programme).
PhD Theses
List of publications
Predictors of Progression in Pre-COPD: The 3P Study Rationale and Design.
González-Villaescusa C, Tarrasó Castillo J, Martínez-Pitarch D, Riesco Miranda JA, García-Castillo E, Gotera Rivera C, Carrasco Hernández L, Sobradillo Ecenarro P, Signes-Costa J, Naval Sendra E, Callejas González FJ, Yordi León A, Vigil Gimenez L, Núñez Fernández M, Palop Cervera M, Carbonell-Asins JA, Agusti A, Field Investigators.
Open Respir Arch. 2026.8(1):100519.
PMID: 41438363
FI: 0
http://dx.doi.org/10.1016/j.opresp.2025.100519
Mortality predictors in pulmonary sarcoidosis: results from the Spanish cohort SARCO-I.
Ramos D, Francesqui J, Bollo E, Villar A, Flórez P, Balcells E, Castaño G, Pinillos-Robles EJ, Godoy-Mayoral R, López-Muñíz B, Soler-Sampere MJ, Castillo D, Rafecas-Codern A, Mariscal-Aguilar P, Gómez-Carrera L, Bonilla G, Millan-Billi P, Portillo K, Hernández-González F, Sellarés J.
Respir Med. 2026 Jan.251:108591.
PMID: 41418888
FI: 3,1
http://dx.doi.org/10.1016/j.rmed.2025.108591
Comparison of Physician Perception Between Single-Use Versus Reusable Flexible Bronchoscope for Basic and Advanced Bronchoscopic Procedures Using Low Fidelity Simulation.
Pu CY, Swenson KE, Uribe F, Flandes J, Avendano CA, Parikh M, Beattie J, Robles J, Majid A.
J Bronchology Interv Pulmonol. 2026 Jan 01.33(1).
PMID: 41216667
FI: 3,2
http://dx.doi.org/10.1097/LBR.0000000000001037
Documento de posicionamiento de Neumomadrid en la inmunización del paciente respiratorio adulto.
Villar-Álvarez F, Raboso-Moreno B, Mínguez-Clemente P, Calderón-Alcalá M, Rodríguez-Hermosa J, de Miguel-Díez J, Calero-Pardo S, Salgado-Aranda S, Gotera-Rivera C.
Rev Pat Resp. 2025.28(Supl 2):115-136.
PMID: 10.24875/RPR.M25000023
FI: 0
http://dx.doi.org/10.24875/RPR.M25000023
Criobiopsia pulmonar transbronquial en enfermedades pulmonares intersticiales: una experiencia multicéntrica.
Echeverri-Hoyos J, Echeverri-Franco JA, Tuta-Quintero E, Sánchez-Vallejo J, Castro-Azcurra R, Flandes J.
Med Int Méx. 2025.41 (10): 598-605.
PMID: 10.24245/mim.v41i10.10567
FI: 0
http://dx.doi.org/10.24245/mim.v41i10.10567
From bench to bedside: Exploring the role of sCD25 in melanoma and lung cancer among sleep apnea patients.
Díaz-García E, Alfaro E, Pérez-Moreno P, López-Fernández C, García-Sánchez A, Martínez-García MÁ, Mañas E, Cano-Pumarega I, Casitas R, Campos-Rodríguez F, Sánchez-de-la-Torre M, Nagore E, Martorell-Calatayud A, Hernández Blasco L, Pastor E, Abad-Capa J, Montserrat JM, Cabriada-Nuño V, Corral-Peñafiel J, Arias E, Mediano O, Somoza-González M, Dalmau-Arias J, Almendros I, Troncoso-Acevedo F, Gotera-Rivera C, Pérez-Warnisher T, Peces-Barba G, Seijo LM, Gozal D, García-Rio F, Cubillos-Zapata C.
Pulmonology. 2025 Dec 31.31(1):2590870.
PMID: 41396725
FI: 6,4
http://dx.doi.org/10.1080/25310429.2025.2590870
Differential DNA methylation in infants with IgE- and non-IgE-mediated cow's milk allergy and its association with acquired tolerance.
López-Gómez R, Gil-Martínez M, Ladrón-Guevara A, Rodrigo-Muñoz JM, Lorente-Sorolla C, Rodríguez-González D, García de Castro Z, Guillén-Sánchez G, Serrano-Santiago A, Mirasierra-Pérez R, Cañas JA, Del Río Camacho G, Del Pozo V.
Front Immunol. 2025.16:1571987.
PMID: 41394805
FI: 5,9
http://dx.doi.org/10.3389/fimmu.2025.1571987
Tracheobronchial metastasis from atypical carcinoid.
Solis AJ, Icaza-Vera J, Flandes J.
J Bras Pneumol. 2025 Dec 05.51(5):e20250267.
PMID: 41370567
FI: 3
http://dx.doi.org/10.36416/1806-3756/e20250267
Uncovering mirnomes of patients with interstitial lung diseases and an underlying autoimmune process.
Sánchez-Pernaute O, Benítez Y, Vadillo Font C, Nieto MA, Cebrián L, López-Muñiz B, Romero-Bueno FI, Godoy H, Laporta R, Del Pozo Abeijón MV, Abásolo Alcázar L, Mínguez P, Rodríguez Nieto MJ.
Respir Res. 2025 Dec 05.
PMID: 41350880
FI: 5
http://dx.doi.org/10.1186/s12931-025-03392-6
High Ferritin Predicts Mortality in Patients With Interstitial Pneumonia and an Underlying Autoimmune Disease.
Rodríguez-Nieto MJ, Romero-Bueno F, Abásolo L, Vegas Sánchez MC, López-Botet Zulueta B, Sánchez-Pernaute O, NEREA Autoimmune ILD Study Group.
Open Respir Arch. 2025.7(3):100455.
PMID: 41054703
FI: 0
http://dx.doi.org/10.1016/j.opresp.2025.100455
Challenges in the Treatment of Obesity Hypoventilation Syndrome With Persistent Nocturnal Hypoxemia: CPAP vs. NIV.
Herrero Huertas J, Esteban Amarilla C, Troncoso Acevedo F, Rodríguez Jerez F, Fortuna Gutiérrez AM.
Open Respir Arch. 2025.7(4):100477.
PMID: 40977910
FI: 0
http://dx.doi.org/10.1016/j.opresp.2025.100477
Optimizing diagnostic yield in pulmonary lesions: impact of combined sampling tools and EBUS-TBNA during radial EBUS.
Tuta-Quintero E, Giraldo-Cadavid LF, Sanmiguel-Reyes C, Navia ME, Cardenas R, Bastidas A, Mora A, Páez-Espinel N, Viola L, Suárez M, Jiménez-Maldonado L, Durán M, Mugnier J, Flandes J.
Ther Adv Respir Dis. 2025.19:17534666251357699.
PMID: 40748006
FI: 3
http://dx.doi.org/10.1177/17534666251357699
Pulmonary Arteriovenous Malformations and Pregnancy: A Case Report.
Icaza Vera J, Alfayate Sánchez J, Rodríguez Guzmán MJ.
Open Respir Arch. 2025.7(3):100454.
PMID: 40686837
FI: 0
http://dx.doi.org/10.1016/j.opresp.2025.100454
Chronic Cavitary Pulmonary Aspergillosis.
Morante Tinoco MM, Montero de Miguel J, Fernández Ormaechea I.
Open Respir Arch. 2025.7(3):100436.
PMID: 40486929
FI: 0
http://dx.doi.org/10.1016/j.opresp.2025.100436
Inspiration Time: The Ultrasound Variable Necessary to Study the Diaphragm Functionality. A Cross-Sectional Controlled Study.
Fernández-Pardo TE, Rodríguez-Nieto MJ, Furió-Valverde M, García-Arrabé M, Mallo-Lopez A, Mahillo-Fernández I, Peces-Barba Romero G.
SAGE Open Nurs. 2025.11:23779608251337591.
PMID: 40297479
FI: 2,5
http://dx.doi.org/10.1177/23779608251337591
Breaking the Glass Ceiling: Open Respiratory Archives Striving for Gender Equity in the Reviewer Field.
Gonzalez-Barcala FJ, Barrecheguren M, de Granda-Orive JI, de Miguel-Díez J, Villar-Álvarez F.
Open Respir Arch. 2025.7(2):100404.
PMID: 39995507
FI: 0
http://dx.doi.org/10.1016/j.opresp.2025.100404
Clustering patients with COVID-19 according to respiratory support requirements, and its impact on short- and long-term outcome (RECOVID study).
Menéndez R, Méndez R, Latorre A, González-Jiménez P, Peces-Barba G, Molina-Molina M, España PP, García E, Consuegra-Vanegas A, García-Clemente MM, Panadero C, Figueira-Gonçalves JM, De la Rosa-Carrillo D, Sibila O, Martínez-Pitarch MD, Toledo-Pons N, López-Ramírez C, Almonte-Batista W, Macías-Paredes A, Villamon M, Domínguez-Álvarez M, Pérez-Rodas EN, Lázaro J, Quirós S, Cordovilla R, Cano-Pumarega I, Torres A, RECOVID.
Pulmonology. 2025 Dec 31.31(1):2442175.
PMID: 39750717
FI: 6,4
http://dx.doi.org/10.1080/25310429.2024.2442175
Real-World Outcomes in Patients with COPD Initiating. Budesonide/Glycopyrronium/Formoterol Fumarate Dehydrate in Spain: ORESTES Study.
Alcázar-Navarrete B, Figueira-Gonçalves JM, Corregidor-García C, Fitas E, Sánchez-Covisa J, ORESTES group (COLABORADORA: Gotera-Rivera C).
Adv Ther. 2025 Nov.42(11):5708-5726.
PMID: 40982160
FI: 4,1
http://dx.doi.org/10.1007/s12325-025-03361-x
Sultiame once per day in obstructive sleep apnoea (FLOW): a multicentre, randomised, double-blind, placebo-controlled, dose-finding, phase 2 trial.
Randerath W, Grote L, Stenlöf K, Fietze I, Chevts J, Buntinx E, Albares J, Kuhn K, Hansen C, Völp A, Hedner J, FLOW study investigators (FLOW study investigators: Troncoso-Acevedo F).
Lancet. 2025 Oct 25.406(10514):1983-1992.
PMID: 41077049
FI: 88,5
http://dx.doi.org/10.1016/S0140-6736(25)01196-1
Uncovering a novel role of nAChRs in oxidative stress-mediated vascular dysfunction in COPD.
Andreu-Martínez R, Munar-Rubert O, Rodríguez-Pérez J, López N, Barreira B, Sánchez-Carretero L, Cardeñosa A, Marcos-Jiménez A, Gandía L, Moreno-Balsalobre R, Milián H, Pérez-Vizcaíno F, Fernández-Malavé E, Peces-Barba G, Muñoz-Calleja C, Cogolludo Á, Calzada MJ.
Redox Biol. 2025 Oct.86:103838.
PMID: 40925126
FI: 11,9
http://dx.doi.org/10.1016/j.redox.2025.103838
Evaluating the Influence of CHI3L1 and PI3 Methylation in Allergic and Nonallergic Asthma.
Baos S, Cremades-Jimeno L, de Pedro MÁ, López-Ramos M, Fernández-Santamaría R, Rosales-Ariza C, Quiralte J, Florido F, González-Mangado N, Rodríguez-Nieto MJ, Peces-Barba G, Sastre J, Cárdaba B.
Biomolecules. 2025 Sep 25.15(10).
PMID: 41154593
FI: 4,8
http://dx.doi.org/10.3390/biom15101363
Cervical Abscess Leading to Mediastinitis and Severe Airway Deviation.
Piñero Gutiérrez P, Olivares Vivanco E, Villar Álvarez F.
Arch Bronconeumol. 2025 Sep 22.
PMID: 41033914
FI: 9,2
http://dx.doi.org/10.1016/j.arbres.2025.09.011
Viral respiratory tract infections diagnosis: a Spanish survey and consensus approach.
Ortiz-de-Lejarazu R, Sagué M, Eiros JM, de la Flor J, Villar-Álvarez F, Fernández-Prada M, Jiménez-Jiménez AB, Sanz F, Gamazo JJ, Yáñez L, Gómez A, Rodríguez-Ledo P, Ortega J, Molero JM, Reina J, Solà-Morales O.
Diagn Microbiol Infect Dis. 2025 Sep.113(1):116831.
PMID: 40354688
FI: 1,8
http://dx.doi.org/10.1016/j.diagmicrobio.2025.116831
Metabolomic Signatures Predict Seven-Year Mortality in Clinically Stable COPD Patients.
Enríquez-Rodríguez CJ, Agranovich B, Pascual-Guàrdia S, Faner R, Camps-Ubach R, Castro-Acosta A, López-Campos JL, Peces-Barba G, Seijo L, Caguana-Vélez OA, Rodríguez-Chiaradia D, Barreiro E, Monsó E, Cosío BG, Abramovich I, Agustí A, Casadevall C, Gea J, On Behalf Of The Biomepoc Group.
Int J Mol Sci. 2025 Jul 02.26(13).
PMID: 40650154
FI: 4,9
http://dx.doi.org/10.3390/ijms26136373
Archivos de Bronconeumología: Elevating Respiratory Research Worldwide.
López-Campos JL, Amado C, Castillo D, López-Padilla D, Méndez R, Seijo L, Villar-Álvarez F.
Arch Bronconeumol. 2025 Jul.61(7):389-390.
PMID: 40610190
FI: 9,2
http://dx.doi.org/10.1016/j.arbres.2025.05.018
Role of antifibrotics in progressive pulmonary fibrosis associated to autoimmune diseases: multicenter study from NEREA registry.
Nieto MA, Vadillo C, Pernaute OS, Romero-Bueno F, Rodriguez-Nieto MJ, Laporta R, Godoy H, Loarce J, Rigual J, Leon L, Abasolo L.
Respir Res. 2025 Jul 02.26(1):234.
PMID: 40604872
FI: 5
http://dx.doi.org/10.1186/s12931-025-03311-9
DHECA score: A decision-making score to identify the need for CPAP treatment beyond the apnea-hypopnea index.
Schönfeld D, Arias S, Pérez-Chada D, Mediano O, Peralta SR, Dibur E, Menéndez M, Solomons D, Barbe F, Gozal D, DHECA Study Group (COLABORADORA: Troncoso Acevedo MF).
Sleep Med. 2025 Jul.131:106499.
PMID: 40209660
FI: 3,4
http://dx.doi.org/10.1016/j.sleep.2025.106499
Catheter-Protected Cryobiopsy of a Peripheral Nodule Using Linear Endobronchial Ultrasound.
Fernández-Navamuel Basozabal I, Recalde Zamacona B, Giménez Velando A, Alfayate Sánchez J, Flandes Aldeyturriaga J.
Arch Bronconeumol. 2025 Jul.61(7):438-439.
PMID: 40175276
FI: 9,2
http://dx.doi.org/10.1016/j.arbres.2025.02.017
Unlocking the secrets of success: enhancing non-invasive respiratory support therapies for improved patient outcomes.
Pisani L, Heili S, Ergan B, Murphy P, Giancotti G, Winck JC.
Expert Rev Respir Med. 2025 Jun 12:1-16.
PMID: 40482042
FI: 2,7
http://dx.doi.org/10.1080/17476348.2025.2518282
Transvascular Needle Aspiration Guide for Ultrasound Bronchoscopy by Esophageal Approach (EUS-B-TVNA), Successful Diagnostic Approach.
Fernández-Navamuel I, Solis AJ, Velando AG.
Arch Bronconeumol. 2025 Jun.61(6):386-387.
PMID: 40187922
FI: 9,2
http://dx.doi.org/10.1016/j.arbres.2025.03.008
Safety and Feasibility of Pulsed Electric Field Ablation for Early-Stage Non-Small Cell Lung Cancer Prior to Surgical Resection.
Jimenez M, Flandes J, van der Heijden EHFM, Ng CSH, Iding JS, Garcia-Hierro JF, Recalde-Zamacona B, Verhoeven RLJ, Lau RWH, Moreno-Gonzalez A, Hatton BA, Seshaiah P, Plentl MB, Krimsky WS.
J Surg Oncol. 2025 Jun.131(8):1529-1542.
PMID: 40152831
FI: 1,9
http://dx.doi.org/10.1002/jso.28110
Lung Diffusing Capacity Improves the Prognostic Validity of the GOLD Spirometric Staging in COPD.
Casanova C, Gonzalez-Dávila E, de Torres JP, Cabrera C, Cosio BG, O'Donnel DE, Martínez-Gonzalez C, Solanes I, Fuster A, Gotera C, Marin A, Amado C, Iscar M, Marin JM, Neder JA, Feu N, Soriano JB, López-Campos JL, Divo M, Peces-Barba G, Celli BR.
Arch Bronconeumol. 2025 May 16.
PMID: 40447521
FI: 9,2
http://dx.doi.org/10.1016/j.arbres.2025.05.004
Rare Association of Right Upper Lobe Agenesis, Dextrocardia, and Aberrant Hepatic Arterial Supply.
Reyes Ussetti J, Montero de Miguel J, Flandes Aldeyturriaga J.
Arch Bronconeumol. 2025 May 15.
PMID: 40436674
FI: 9,2
http://dx.doi.org/10.1016/j.arbres.2025.05.003
Metabolomic Plasma Profile of Chronic Obstructive Pulmonary Disease Patients.
Casadevall C, Agranovich B, Enríquez-Rodríguez CJ, Faner R, Pascual-Guàrdia S, Castro-Acosta A, Camps-Ubach R, Garcia-Aymerich J, Barreiro E, Monsó E, Seijo L, Soler-Cataluña JJ, Santos S, Peces-Barba G, López-Campos JL, Casanova C, Agustí A, Cosío BG, Abramovich I, Gea J, EARLY COPD and BIOMEPOC Groups.
Int J Mol Sci. 2025 May 09.26(10).
PMID: 40429672
FI: 4,9
http://dx.doi.org/10.3390/ijms26104526
Development and Validation of the Bronchoscope Quality Questionnaire for Assessing Bronchoscopists' Perception of Single-Use Flexible Bronchoscope Quality.
Flandes J, Cerchiaro-Torrado LV, Disdier C, Alfayate J, Fernandez-Navamuel I, Augustí C, Lucena CM, Martinez-Muñiz F, Pajares V, Andreo F, Centeno C, Montero C, Ariza M, Tuta-Quintero E, Gallego R, Torregó A, González H, Cordovilla R, Vega-Sanchez B, Cascón J, García-López JJ, García-Gallo CL, Díaz-Agero P, Luque-Crespo E, Pavón-Masa M, Cases E, Robles J, Uribe-Hernández AM, Giraldo-Cadavid LF.
Respiration. 2025 Apr 29:1-10.
PMID: 40300585
FI: 3,8
http://dx.doi.org/10.1159/000546088
Immune Checkpoint Biomarkers Galectin-9 and TIM-3 Predict Melanoma and Lung Cancer Mortality in Obstructive Sleep Apnoea.
Díaz-García E, Alfaro E, Pérez-Moreno P, López-Fernández C, García-Sánchez A, Martínez-García MÁ, Mañas E, Cano-Pumarega I, Casitas R, Campos-Rodríguez F, Sánchez-de-la-Torre M, Nagore E, Martorell-Calatayud A, Hernández Blasco L, Pastor E, Abad-Capa J, María Montserrat J, Cabriada-Nuño V, Corral-Peñafiel J, Arias E, Mediano O, Somoza-González M, Dalmau-Arias J, Almendros I, Troncoso-Acevedo F, Gotera-Rivera C, Pérez-Warnisher T, Peces-Barba G, Seijo LM, Gozal D, García-Rio F, Cubillos-Zapata C.
Arch Bronconeumol. 2025 Apr 02.
PMID: 40287376
FI: 9,2
http://dx.doi.org/10.1016/j.arbres.2025.03.018
Ventilatory Response to Exercise in HFrEF-COPD: Importance of Exercise Modality.
Íscar Urrutia M, Huertas JH, Castro MA, Fernández Álvarez R, Molina BD, Clemente MG.
J Clin Med. 2025 Apr 08.14(8).
PMID: 40283369
FI: 2,9
http://dx.doi.org/10.3390/jcm14082538
A Micro-costing Analysis of Single-use and Reusable Flexible Bronchoscope Usage in the Bronchoscopy Service at A Tertiary Care University Hospital.
Flandes J, Giménez A, Álvarez S, Giraldo-Cadavid LF.
J Bronchology Interv Pulmonol. 2025 Apr 01.32(2).
PMID: 40051085
FI: 3,2
http://dx.doi.org/10.1097/LBR.0000000000001008
Monitoring peripheral blood data supports the prediction of immunotherapy response in advanced non-small cell lung cancer based on real-world data.
Ramos-Guerra AD, Farina B, Rubio Pérez J, Vilalta-Lacarra A, Zugazagoitia J, Peces-Barba G, Seijo LM, Paz-Ares L, Gil-Bazo I, Dómine Gómez M, Ledesma-Carbayo MJ.
Cancer Immunol Immunother. 2025 Feb 25.74(4):120.
PMID: 39998679
FI: 5,1
http://dx.doi.org/10.1007/s00262-025-03966-9
Bronchoscopic Pulsed Electric Field for Ablation and Inmunomodulation in Early-stage Non-small Lung Cancer: A Case Report.
Recalde-Zamacona B, Giménez A, Alfayate J, Reyes J, Fernandez-Navamuel I, Flandes J.
Open Respir Arch. 2024 Oct.6(Suppl 2):100457.
PMID: 40704295
FI: 0
http://dx.doi.org/10.1016/j.opresp.2025.100457
Projects, contracts and observational studies
PUBLIC
Sources of public funding for projects being developed at the IIS-FJD:
|
REFERENCE |
PROJECT TITLE |
PRINCIPAL RESEARCHER |
TYPE OF PROJECT |
TOTAL FUNDING |
|
SHAPE |
SISTEMA HOSPITALARIO DE ACTIVIDAD FÍSICA Y PARTICIPACIÓN ACTIVA |
VILLAR ALVAREZ, FELIPE |
CLINICAL RESEARCH PROJECTS. INTERNATIONAL |
€46,564.88 |
|
PMP21/00090 |
PREDICCIÓN, PREVENCIÓN, MANEJO PERSONALIZADO Y DE PRECISIÓN DE LA ENFERMEDAD CRÓNICA PULMONAR (EPOC) EN ADULTOS JÓVENES |
GOTERA RIVERA, CAROLINA |
CLINICAL RESEARCH PROJECTS. ISCIII |
€8,250.00 |
|
CPP2021-008336 |
DESARROLLO DE UN TEST EN SANGRE PARA EL DIAGNÓSTICO PRECOZ DEL CÁNCER DE PULMÓN BASADO EN MARCADORES MOLECULARES, IMÁGENES Y HERRAMIENTAS BIG DATA (ONCOLUNG DX) |
RODRIGUEZ NIETO, MARIA JESUS |
CLINICAL RESEARCH PROJECTS. MINISTRY |
€227,122.95 |
PRIVATE
|
REFERENCE |
PROJECT TITLE |
PRINCIPAL RESEARCHER |
TYPE OF PROJECT |
|
2024.097 |
DESARROLLO DE ÍNDICES DE SALUD PARA CETÁCEOS Y VIGILANCIA DE PATÓGENOS EN LA INTERACCIÓN HUMANO-CETÁCEO |
HEILLI FRADES, SARA BEATRIZ |
RESEARCH PROJECTS |
|
EO093-22_FJD |
REGISTRO DE PACIENTES INCLUIDOS EN EL PROGRAMA DEPRECAP (DETECCIÓN PRECOZ DEL CÁNCER DE PULMÓN MEDIANTE TOMOGRAFÍA AXIAL COMPUTARIZADA DE BAJA DOSIS (TBD)). |
GOTERA RIVERA, CAROLINA |
OBSERVATIONAL STUDIES |
|
EOH041-24_FJD |
OBSERVATIONAL RETROSPECTIVE STUDY TO DESCRIBE CHARACTERISTICS AND EVALUATE REAL-WORLD OUTCOMES IN PATIENTS INITIATING TRIXEO AEROSPHERE (BUDESONIDE/GLYCOPYRRONIUM BROMIDE/FORMOTEROL FUMARATE) IN SPAIN. ORESTES |
GOTERA RIVERA, CAROLINA |
OBSERVATIONAL STUDIES |
|
EOH066-25_FJD |
OBESITY MANAGEMENT IN PEOPLE WITH OBSTRUCTIVE SLEEP APNEA IN ROUTINE CLINICAL PRACTICE SETTINGS IN SPAIN: O-MISSION STUDY |
TRONCOSO ACEVEDO, MARIA FERNANDA |
OBSERVATIONAL STUDIES |
|
PIC020-25_FJD |
ESTUDIO PROSPECTIVO MULTICÉNTRICO PARA LA APLICACIÓN DE LA TECNOLOGÍA DE LA MEDICIÓN TELOMÉRICA COMO HERRAMIENTA PARA EL DIAGNÓSTICO DE CÁNCER DE PULMÓN" (PNEUMOTAV001) |
GOTERA RIVERA, CAROLINA |
RESEARCH PROJECTS |
|
PIC187-23_FJD |
ESTUDIO DE OBTENCIÓN DE PRUEBAS PARA LA DETECCIÓN DE CÁNCER DE ROCHE |
GOTERA RIVERA, CAROLINA |
RESEARCH PROJECTS |
|
PIC120-22_FJD |
ESTUDIO PILOTO PARA EVALUAR LA UTILIDAD DEL DISPOSITIVO EMILY EN LA REGULACIÓN AUTOMÁTICA DE LOS NIVELES DE SATURACIÓN DE OXÍGENO EN SANGRE EN PACIENTES CON INSUFICIENCIA RESPIRATORIA AGUDA |
HEILLI FRADES, SARA BEATRIZ |
RESEARCH PROJECTS |
|
PIC251-23_FJD |
ESTUDIO DE VALIDACIÓN FUNCIONAL, CLÍNICO Y PREDICTIVO DEL DISPOSITIVO EMILY AI EN PACIENTES CON INSUFICIENCIA RESPIRATORIA AGUDA Y CRÓNICA. |
HEILLI FRADES, SARA BEATRIZ |
RESEARCH PROJECTS |
|
PIC295-23_HGV |
PROYECTO CASSANDRA (CANCER SCREENING, SMOKING CESSATION AND RESPIRATORY ASSESSMENT) - CRIBADO DEL CÁNCER DE PULMÓN MEDIANTE TC DE BAJA DOSIS PROYECTO PILOTO NACIONAL |
LOPEZ CHANG, CARLOS |
RESEARCH PROJECTS |
|
PIC128-24_FJD-HGV |
DESARROLLO E IMPLANTACIÓN DE UNA VÍA CLÍNICA PARA LA DETECCIÓN DE PACIENTES CON ASMA NO CONTROLADA QUE ASISTEN AL SERVICIO DE URGENCIAS |
RODRIGUEZ NIETO, MARIA JESUS |
RESEARCH PROJECTS |
|
PIC172-24_FJD |
PROYECTO DE INNOVACIÓN EN EL PACIENTE CON ENFERMEDAD AUTOINMUNE Y AFECTACIÓN PULMONAR |
RODRIGUEZ NIETO, MARIA JESUS |
RESEARCH PROJECTS |
|
PIC010-25_FJD |
INFECCIÓN POR VIRUS RESPIRATORIO SINCITIAL EN LAS EXACERBACIONES DE LA ENFERMEDAD PULMONAR OBSTRUCTIVA CRÓNICA |
VILLAR ALVAREZ, FELIPE |
RESEARCH PROJECTS |
|
PIC171-24_FJD |
PROPUESTA ANTES. UNA NUEVA APROXIMACIÓN PARA EL PACIENTE CON EPOC QUE EXACERBA (ESTUDIO EXACERBANTES) |
VILLAR ALVAREZ, FELIPE |
RESEARCH PROJECTS |
|
00400072 |
CURIOSITY. AVANZANDO EN EL DIAGNÓSTICO DEL PACIENTE CON CÁNCER DE PULMÓN |
FLANDES ALDEYTURRIAGA, JAVIER |
TRAINING/TEACHING |
|
00400014 |
PROGRAMA HUFJD_UCIR 2024/2025 |
HEILLI FRADES, SARA BEATRIZ |
TRAINING/TEACHING |
|
00400068 |
TALLER TEÓRICO PRÁCTICO EN HABILIDADES PARA EL MANEJO DEL PACIENTE SEMICRÍTICO EN CUIDADOS INTERMEDIOS EN FORMATO PRESENCIAL (14 DE OCTUBRE DE 2025) |
HEILLI FRADES, SARA BEATRIZ |
TRAINING/TEACHING |
|
00400037 |
SIMPOSIO SOSTENIBILIDAD EN EL SECTOR SALUD |
VILLAR ALVAREZ, FELIPE |
TRAINING/TEACHING |
Clinical trials
The clinical trials listed below were in the recruitment phase in 2025. If you are interested in participating in any of the currently open trials, more information is available on the website (https://ensayos.quironsalud.es/)
|
EudraCT Number |
TITLE |
PHASE |
MC1 |
INT2 |
PRINCIPAL RESEARCHER |
|
2025-520488-42-00 |
ESTUDIO EN FASE IIB, ALEATORIZADO, DOBLE CIEGO, CONTROLADO ON PLACEBO Y DE GRUPOS PARALELOS PARA EVALUAR LA EFICACIA Y LA SEGURIDAD DE VERKITUG (UPB-101) EN PARTICIPANTES CON ENFERMEDAD PULMONAR OBSTRUCTIVA CRÓNICA (EPOC) DE MODERADA A GRAVE. |
II |
YES |
YES |
CAROLINA GOTERA RIVERA |
|
2025-523009-14-00 |
ENSAYO DE FASE IIB, ALEATORIZADO, DOBLE CIEGO, CONTROLADO CON PLACEBO, PARALELO, DE DOSIS MÚLTIPLE PARA EVALUAR LA EFICACIA, SEGURIDAD Y FARMACOCINÉTICA DE AZD0292 EN PARTICIPANTES DE 12 AÑOS DE EDAD EN ADELANTE Y ADULTOS CON BRONQUIECTASIAS Y COLONIZACIÓN POR PSEUDOMONAS AERUGINOSA. |
II |
YES |
YES |
CAROLINA GOTERA RIVERA |
|
2021-002045-15 |
ESTUDIO DE FASE IIB, MULTICÉNTRICO, ALEATORIZADO, DOBLE CIEGO Y CONTROLADO CON PLACEBO PARA EVALUAR LA EFICACIA Y LA SEGURIDAD DEL ASTEGOLIMAB EN PACIENTES CON ENFERMEDAD PULMONAR OBSTRUCTIVA CRÓNICA. |
III |
YES |
YES |
CAROLINA GOTERA RIVERA |
|
2022-501063-41-00 |
A PHASE III, MULTICENTRE, RANDOMISED, DOUBLE-BLIND, CHRONIC-DOSING, PARALLEL-GROUP, PLACEBO-CONTROLLED EXTENSION STUDY TO EVALUATE THE LONG-TERM EFFICACY AND SAFETY OF TOZORAKIMAB IN PARTICIPANTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) WITH A HISTORY OF EXACERBATIONS (PROSPERO) |
III |
YES |
NO |
CAROLINA GOTERA RIVERA |
|
2022-502501-15-00 |
A PHASE III OPEN-LABEL EXTENSION STUDY TO EVALUATE THE LONG-TERM SAFETY OF ASTEGOLIMAB IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
III |
YES |
YES |
CAROLINA GOTERA RIVERA |
|
2023-503571-19-00 |
ENSAYO FASE III, MULTICÉNTRICO, ALEATORIZADO, DOBLE CIEGO, DE GRUPOS PARALELOS, DOSIS CRÓNICA Y CONTROLADO CON PLACEBO, PARA EVALUAR LA EFICACIA Y SEGURIDAD DE DOS DOSIS DE MEDI3506 EN PACIENTES CON ENFERMEDAD PULMONAR OBSTRUCTIVA CRÓNICA (EPOC) SINTOMÁTICA Y CON HISTORIAL DE EXACERBACIONES DE LA EPOC (OBERON) |
III |
YES |
YES |
CAROLINA GOTERA RIVERA |
|
2023-508085-15-00 |
A DOUBLE-BLINDED EXTENSION STUDY TO EVALUATE THE LONG-TERM SAFETY AND TOLERABILITY OF ITEPEKIMAB IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) WHO PARTICIPATED IN EITHER EFC16750 OR EFC16819 CLINICAL STUDIES |
III |
YES |
YES |
CAROLINA GOTERA RIVERA |
|
2024-520418-22-00 |
ESTUDIO MULTICÉNTRICO, ALEATORIZADO, DOBLE CIEGO, CONTROLADO CON PLACEBO Y DE GRUPOS PARALELOS PARA EVALUAR LA EFICACIA Y LA SEGURIDAD DEL DEPEMOKIMAB EN PARTICIPANTES ADULTOS CON EPOC E INFLAMACIÓN DE TIPO 2 |
III |
YES |
YES |
CAROLINA GOTERA RIVERA |
|
2023-503693-20-00 |
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY TO ASSESS THE EFFICACY, SAFETY, AND TOLERABILITY OF DEXPRAMIPEXOLE ADMINISTERED ORALLY FOR 52 WEEKS IN PARTICIPANTS WITH SEVERE EOSINOPHILIC ASTHMA (EXHALE-3) |
III |
YES |
YES |
MARIA JESUS RODRIGUEZ NIETO |
|
2023-503697-21-01 |
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 3 STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF BMS-986278 IN PARTICIPANTS WITH IDIOPATHIC PULMONARY FIBROSIS |
III |
YES |
YES |
MARIA JESUS RODRIGUEZ NIETO |
|
2023-503699-25-00 |
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 3 STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF BMS-986278 IN PARTICIPANTS WITH PROGRESSIVE PULMONARY FIBROSIS |
III |
YES |
YES |
MARIA JESUS RODRIGUEZ NIETO |
|
2023-507304-32-00 |
THE ANTES B+ STUDY: AN OPENLABEL, PRAGMATIC, RANDOMIZED, CONTROLLED TRIAL OF TRIPLE THERAPY VERSUS LABA-LAMA COMBINATION TO IMPROVE CLINICAL CONTROL IN HIGH-RISK GOLD B PATIENTS (B+) |
IV |
YES |
NO |
CAROLINA GOTERA RIVERA |
|
2025-521268-37-00 |
ESTUDIO ALEATORIZADO, DOBLE CIEGO Y CONTROLADO CON PLACEBO PARA EVALUAR EL EFECTO DE DUPILUMAB SOBRE LA INFLAMACIÓN DE LAS VÍAS RESPIRATORIAS A TRAVÉS DE EVALUACIONES DEL TAPONAMIENTO MUCOSO Y OTROS PARÁMETROS DE IMAGEN PULMONAR EN PACIENTES CON ENFERMEDAD PULMONAR OBSTRUCTIVA CRÓNICA. |
IV |
YES |
YES |
CAROLINA GOTERA RIVERA |
|
NA |
ESTUDIO COMPARATIVO DE LA OXIGENOTERAPIA ADMINISTRADA MEDIANTE ALTO FLUJO POR CÁNULA NASAL Y OTROS DISPOSITIVOS DE OXIGENOTERAPIA EN PACIENTES SOMETIDOS A EBUS-TBNA |
NA |
NO |
NO |
ANDRES GIMENEZ VELANDO |
|
NA |
ENSAYO ALEATORIZADO CONTROLADO DE NO INFERIORIDAD PARA EL ANÁLISIS COSTE-EFECTIVIDAD Y RESPUESTA CONDICIONADA AL EFECTO DE LOS DISPOSITIVOS POSICIONALES ACTIVOS EN LA APNEA OBSTRUCTIVA DEL SUEÑO POSICIONAL. ESTUDIO PÁVLOV |
NA |
YES |
NO |
MARIA FERNANDA TRONCOSO ACEVEDO |
|
NA |
BENEFICIOS DE LA TERAPIA DE ALTO FLUJO EN LA EXACERBACIÓN MUY GRAVE DE LA EPOC FRENTE A OXIGENOTERAPIA CONVENCIONAL DURANTE EL DESTETE DE VMNI |
NA |
NO |
NO |
SARA BEATRIZ HEILLI FRADES |
|
MC1: MULTICENTRE INT2: INTERNATIONAL |
|||||
